Sanofi-Aventis pays up for Eu3.7bn extension

French pharmaceuticals group Sanofi-Aventis has secured a Eu3.7bn one year extension to an outstanding loan maturing next week, after agreeing to increase the margin and commitment fee. The new loan, which will become effective on January 14 and is one of the first chunky deals to be completed this year, replaces a Eu4.08bn facility signed in 2008.

  • 06 Jan 2009

This in turn was an extension of a Eu5bn facility from 2005.

The margin will this time be increased to 40bp from 10bp, and Sanofi will pay lenders a commitment fee of 13bp instead of the 8.5bp originally discussed. There will also be a utilisation fee of 15bp ...

Please take a trial or subscribe to access this content.

Contact Mark Goodes to discuss your access:

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: or find out more online here.

New! GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Citi 7,171 21 10.72
2 Bank of America Merrill Lynch (BAML) 6,901 20 10.32
3 JP Morgan 4,776 10 7.14
4 Credit Suisse 4,718 9 7.05
5 Lloyds Bank 4,420 14 6.61

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Wells Fargo Securities 68,611.22 170 11.38%
2 Bank of America Merrill Lynch 59,056.08 169 9.80%
3 JPMorgan 56,861.85 163 9.43%
4 Citi 56,521.05 165 9.38%
5 Credit Suisse 44,888.95 123 7.45%